NeuroBo Pharmaceuticals, Inc. NRBO
2.36 +2.36
Day range unavailable
52-week range unavailable
Latest period ending Dec 31, 2023 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|---|
| 15.89M | 19.63M | 15.30M | 29.72M | 20.18M | |
| 9.16M | 2.78M | 6.55M | 4.53M | 5.32M | |
| 6.73M | 8.64M | 8.75M | 7.85M | 2.70M | |
| -15.89M | -19.63M | -15.30M | -29.72M | -20.18M | |
| -12.47M | -13.97M | -15.28M | -29.68M | -21.31M | |
| -12.47M | -13.97M | -15.28M | -29.68M | -21.31M | |
| -12.47M | -13.97M | -15.28M | -29.68M | -21.31M | |
| -12.47M | -13.97M | -15.28M | -29.68M | -21.31M | |
| -2.46 | -43.42 | -158.48 | -439.24 | -979.30 | |
| -2.46 | -43.42 | -158.48 | -439.24 | -979.30 | |
| -2.46 | -43.42 | -158.48 | -439.24 | -979.30 | |
| -12.47M | -11.78M | -15.28M | -29.68M | -21.29M | |
| -12.47M | -11.78M | -15.28M | -29.68M | -21.29M | |
| 5.07M | 321.70K | 96.43K | 67.56K | 21.77K | |
| 5.07M | 321.70K | 96.43K | 67.56K | 21.77K |